Status:

UNKNOWN

SOLIDARITY Finland Plus Long-COVID

Lead Sponsor:

Clinical Urology and Epidemiology Working Group

Collaborating Sponsors:

University of Helsinki

World Health Organization

Conditions:

Covid19

Coronavirus Disease 2019

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The SOLIDARITY PLUS Finland Long-COVID trial aims to assess the long-term effects of imatinib and infliximab, used during acute hospitalization due to COVID-19-infection, on long-COVID symptoms and qu...

Detailed Description

The SOLIDARITY Finland Plus Long-COVID is the long-term follow-up of the SOLIDARITY Finland Plus trial. With local adjustments, this clinical trial follows the WHO core protocol. SOLIDARITY Finland (P...

Eligibility Criteria

Inclusion

  • Adult patients, 18 years and above
  • SARS-2-CoV-2 infection, laboratory-confirmed
  • Admission to the hospital ward or ICU
  • Written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself.
  • No anticipated transfer within 72 hours to a non-study hospital

Exclusion

  • Estimated life expectancy under three months due to severe comorbidity
  • ASAT/ALAT-ratio over five-fold upper limit
  • Acute myocardial infarction or unstable angina pectoris
  • Breast feeding or pregnancy
  • Any reason why, in the opinion of the investigators, the patient should not participate
  • Patient participates in a potentially confounding drug or device trial during the course of the study
  • Already receiving any of the study drugs
  • Severe renal failure (eGFR \< 30 mL/min)

Key Trial Info

Start Date :

February 6 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT05220280

Start Date

February 6 2022

End Date

December 1 2025

Last Update

May 3 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Helsinki

Helsinki, Finland, 00014